Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Retained-Earnings" stands at 72.23 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Retained Earnings" stands at 72.23 Billion USD. This represents an increase of 5.48 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 17.67 percent compared to the value the year prior.
The 1 year change in percent is 17.67.
The 3 year change in percent is 20.53.
The 5 year change in percent is 41.33.
The 10 year change in percent is 58.19.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Retained Earnings | 486,508,953,600.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Retained Earnings | 280,205,508,085.11 |